For WILLIAM C. STEERE JR., 59-year-old CEO of Pfizer, the big payoff came in 1995. He sold off nondrug operations and refused to shell out billions for distributors, as rivals have. Instead, the avid helicopter skier has focused on riskier new products. Driven by antidepressant Zoloft and antihypertensive Norvasc, Pfizer's net income in 1995 rose 20%, to nearly $1.56 billion, while sales gained 23%, to $10.2 billion.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE